Although MYCN amplification is associated to the progression of the disease [5,8], our results indicate that hypoxia is related to the aggressiveness of neuroblastoma independently from MYCN amplification and it might be responsible for increasing the risk of poor outcome in patients with a more favorable biology. Here, MYCN is linked to neuroblastoma.